Matches in Nanopublications for { ?s ?p "[Overexpression of human EGF receptor HER-2 (erbB2) leads to amplified heregulin (HRG) signaling, promoting more aggressive breast cancer that is nonresponsive to estrogen and the antiestrogenic drug tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP419539.RAf6joGscJShy4s0lk4NFEKGhChAfZENspN1tzWZSlXvU130_assertion description "[Overexpression of human EGF receptor HER-2 (erbB2) leads to amplified heregulin (HRG) signaling, promoting more aggressive breast cancer that is nonresponsive to estrogen and the antiestrogenic drug tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419539.RAf6joGscJShy4s0lk4NFEKGhChAfZENspN1tzWZSlXvU130_provenance.
- NP419541.RAj5mYSFuHCN4tZQ3CIBeARrxkKJBBAaX7PZAK8Digotk130_assertion description "[Overexpression of human EGF receptor HER-2 (erbB2) leads to amplified heregulin (HRG) signaling, promoting more aggressive breast cancer that is nonresponsive to estrogen and the antiestrogenic drug tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419541.RAj5mYSFuHCN4tZQ3CIBeARrxkKJBBAaX7PZAK8Digotk130_provenance.